Danpha receives ground for VND1.5 trillion Danang nanotechnology project
Danang Pharmaceutical Joint Stock Company (Danapha) has become the third investor to try their hands at developing project in Danang Hi-Tech Park, after the flight of the two Japanese enterprises Tokyo Keiki Precision Technology Inc and Niwa Foundry.
 |
Earlier in June, the Danang Hi-Tech Park Management Board granted the investment certificate for the investor to start construction in January 2017. According to plans, the project will be implemented in three phases.
The first phase, with an investment capital of VND500 billion ($22.5 million), will have an annual output capacity of 1 billion tablets, while the second and third phases will provide an output capacity of 100 million units of injectable drugs.
The last two phases will have an investment capital of VND600 billion (427.01 million) and VND400 billion ($18.01 million), respectively.
The factory is expected to come into full capacity operation in December 2021.
Danapha also started an alternative Asian pharmaceutical manufacturing factory in Hoa Khanh industrial park in Danang in 2009, its first plant meeting GMP-WHO (good manufacturing practices as recommended by the World Health Organisation) standards.
In addition, it has completed research on a nanotechnology-based cancer injection that could lead to cheaper cancer treatment in the central region.
